Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Breast Cancer

  Free Subscription


Articles published in Clin Breast Cancer

Retrieve available abstracts of 123 articles:
HTML format
Text format



Single Articles


    March 2017
  1. ZHANG X, Bleiweiss I, Jaffer S, Nayak A, et al
    The Impact of 2013 Updated ASCO/CAP HER2 Guidelines on the Diagnosis and Management of Invasive Breast Cancer: A Single-Center Study of 1739 Cases.
    Clin Breast Cancer. 2017 Mar 29. pii: S1526-8209(16)30360.
    PubMed     Text format     Abstract available


  2. MENDEZ-HERNANDEZ A, Gallegos-Arreola MP, Moreno-Macias H, Espinosa Fematt J, et al
    LEP rs7799039, LEPR rs1137101, and ADIPOQ rs2241766 and 1501299 Polymorphisms Are Associated With Obesity and Chemotherapy Response in Mexican Women With Breast Cancer.
    Clin Breast Cancer. 2017 Mar 22. pii: S1526-8209(16)30246.
    PubMed     Text format     Abstract available


  3. WADASADAWALA T, Vadgaonkar R, Bajpai J
    Management of Isolated Locoregional Recurrences in Breast Cancer: A Review of Local and Systemic Modalities.
    Clin Breast Cancer. 2017 Mar 21. pii: S1526-8209(16)30416.
    PubMed     Text format     Abstract available


  4. GINTER PS, McIntire PJ, Cui X, Irshaid L, et al
    Folate Receptor Alpha Expression Is Associated With Increased Risk of Recurrence in Triple-negative Breast Cancer.
    Clin Breast Cancer. 2017 Mar 21. pii: S1526-8209(17)30012.
    PubMed     Text format     Abstract available


  5. VIDAL GA, Chen M, Sheth S, Svahn T, et al
    Phase I Trial of Everolimus and Capecitabine in Metastatic HER2- Breast Cancer.
    Clin Breast Cancer. 2017 Mar 16. pii: S1526-8209(16)30410.
    PubMed     Text format     Abstract available


  6. BERNARDO A, Palumbo R, Pedersini R, Rota Caremoli E, et al
    Nab-Paclitaxel in Advanced HER2-negative Breast Cancer Patients: Efficacy and Safety Beyond Clinical Trials.
    Clin Breast Cancer. 2017 Mar 9. pii: S1526-8209(16)30359.
    PubMed     Text format     Abstract available


  7. CHAND AR, Ziauddin MF, Tang SC
    Can Locoregionally Recurrent Breast Cancer Be Cured?
    Clin Breast Cancer. 2017 Mar 2. pii: S1526-8209(17)30113.
    PubMed     Text format     Abstract available


    February 2017
  8. ALTUNDAG K
    Flap Fixation Using Tissue Glue or Sutures After Mastectomy Might Also Reduce Risk of Developing Lymphedema in Breast Cancer.
    Clin Breast Cancer. 2017 Feb 20. pii: S1526-8209(17)30061.
    PubMed     Text format    


  9. ALTUNDAG K
    Molecular Subtypes and Lower Inner Quadrant Tumors in Breast Cancer: Debate Is Still Ongoing.
    Clin Breast Cancer. 2017 Feb 17. pii: S1526-8209(17)30019.
    PubMed     Text format    


  10. REZENDE LM, Marson FA, Lima CS, Bertuzzo CS, et al
    Can MTHFR C677T and A1298C Polymorphisms Alter the Risk and Severity of Sporadic Breast Cancer in Brazilian Women?
    Clin Breast Cancer. 2017 Feb 16. pii: S1526-8209(16)30341.
    PubMed     Text format     Abstract available


  11. WANG CH, Chang CJ, Yeh KY, Chang PH, et al
    The Prognostic Value of HER2-Positive Circulating Tumor Cells in Breast Cancer Patients: A Systematic Review and Meta-Analysis.
    Clin Breast Cancer. 2017 Feb 16. pii: S1526-8209(17)30086.
    PubMed     Text format     Abstract available


    January 2017
  12. LEFEUVRE D, Le Bihan-Benjamin C, Pauporte I, Medioni J, et al
    French Medico-Administrative Data to Identify the Care Pathways of Women With Breast Cancer.
    Clin Breast Cancer. 2017 Jan 27. pii: S1526-8209(16)30321.
    PubMed     Text format     Abstract available


  13. VAN BASTELAAR J, Theunissen LL, Snoeijs MG, Beets GL, et al
    Flap Fixation Using Tissue Glue or Sutures Appears to Reduce Seroma Aspiration After Mastectomy for Breast Cancer.
    Clin Breast Cancer. 2017 Jan 24. pii: S1526-8209(16)30565.
    PubMed     Text format     Abstract available


  14. DE BOER MC, Worner EA, Verlaan D, van Leeuwen PA, et al
    The Mechanisms and Effects of Physical Activity on Breast Cancer.
    Clin Breast Cancer. 2017 Jan 24. pii: S1526-8209(16)30422.
    PubMed     Text format     Abstract available


  15. CHAPMAN JW, Liu S, Leung S, Nielsen TO, et al
    Competing Risks of Mortality by PAM50 Intrinsic Subtype of British Columbia Tamoxifen-Treated Cohort of Postmenopausal Patients With Breast Cancer.
    Clin Breast Cancer. 2017 Jan 20. pii: S1526-8209(16)30362.
    PubMed     Text format     Abstract available


  16. LI G, Xu Z, Zhuang A, Chang S, et al
    Magnetic Resonance Spectroscopy-Detected Change in Marrow Adiposity Is Strongly Correlated to Postmenopausal Breast Cancer Risk.
    Clin Breast Cancer. 2017 Jan 18. pii: S1526-8209(17)30011.
    PubMed     Text format     Abstract available


  17. GHONCHEH M, Ziaee F, Karami M, Poorolajal J, et al
    Validating the IBIS and BOADICEA Models for Predicting Breast Cancer Risk in the Iranian Population.
    Clin Breast Cancer. 2017 Jan 18. pii: S1526-8209(17)30010.
    PubMed     Text format     Abstract available


  18. GU YL, Pan SM, Ren J, Yang ZX, et al
    Role of Magnetic Resonance Imaging in Detection of Pathologic Complete Remission in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: A Meta-analysis.
    Clin Breast Cancer. 2017 Jan 11. pii: S1526-8209(16)30256.
    PubMed     Text format     Abstract available


  19. SCHRAMM A, Schochter F, Friedl TW, de Gregorio N, et al
    Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast Cancer.
    Clin Breast Cancer. 2017 Jan 10. pii: S1526-8209(16)30257.
    PubMed     Text format     Abstract available


  20. HWANG KT, Kim J, Kim EK, Jung SH, et al
    Poor Prognosis of Lower Inner Quadrant in Lymph Node-negative Breast Cancer Patients Who Received No Chemotherapy: A Study Based on Nationwide Korean Breast Cancer Registry Database.
    Clin Breast Cancer. 2017 Jan 10. pii: S1526-8209(16)30269.
    PubMed     Text format     Abstract available


  21. CONVERSANO A, Mazouni C, Thomin A, Gaudin A, et al
    Use of Low-Thrombin Fibrin Sealant Glue After Axillary Lymphadenectomy for Breast Cancer to Reduce Hospital Length and Seroma.
    Clin Breast Cancer. 2017 Jan 10. pii: S1526-8209(16)30449.
    PubMed     Text format     Abstract available


  22. GOLSE N, Adam R
    Liver Metastases From Breast Cancer: What Role for Surgery? Indications and Results.
    Clin Breast Cancer. 2017 Jan 9. pii: S1526-8209(16)30298.
    PubMed     Text format     Abstract available


  23. NYE L, Rademaker A, Gradishar WJ
    Breast Cancer Outcomes After Diagnosis of Hormone-positive Breast Cancer and Subsequent Pregnancy in the Tamoxifen Era.
    Clin Breast Cancer. 2017 Jan 9. pii: S1526-8209(16)30313.
    PubMed     Text format     Abstract available


  24. MURPHY BL, Boughey JC, Hieken TJ
    Nipple-sparing Mastectomy for the Management of Recurrent Breast Cancer.
    Clin Breast Cancer. 2017 Jan 9. pii: S1526-8209(16)30355.
    PubMed     Text format     Abstract available


  25. ALTUNDAG K
    New Data About First-line All-oral Vinorelbine and Capecitabine in HER2-negative Metastatic Breast Cancer Confirms Results of Meta-analysis.
    Clin Breast Cancer. 2017 Jan 9. pii: S1526-8209(16)30426.
    PubMed     Text format    


  26. ALTUNDAG K
    Genomic Profiling of Brain Metastasis and Matched Primary Triple-negative Breast Cancer.
    Clin Breast Cancer. 2017 Jan 9. pii: S1526-8209(16)30409.
    PubMed     Text format    


  27. SHEPPARD VB, Cavalli LR, Dash C, Kanaan YM, et al
    Correlates of Triple Negative Breast Cancer and Chemotherapy Patterns in Black and White Women With Breast Cancer.
    Clin Breast Cancer. 2017 Jan 6. pii: S1526-8209(16)30571.
    PubMed     Text format     Abstract available


  28. DENU RA, Burkard ME
    Synchronous Bilateral Breast Cancer in a Patient With Nager Syndrome.
    Clin Breast Cancer. 2017 Jan 5. pii: S1526-8209(16)30577.
    PubMed     Text format    


    December 2016
  29. JONES EF, Ray KM, Li W, Seo Y, et al
    Dedicated Breast Positron Emission Tomography for the Evaluation of Early Response to Neoadjuvant Chemotherapy in Breast Cancer.
    Clin Breast Cancer. 2016 Dec 29. pii: S1526-8209(16)30576.
    PubMed     Text format    


  30. YAN M, Wang J, Xuan Q, Dong T, et al
    The Relationship Between Tamoxifen-associated Nonalcoholic Fatty Liver Disease and the Prognosis of Patients With Early-stage Breast Cancer.
    Clin Breast Cancer. 2016 Dec 24. pii: S1526-8209(16)30569.
    PubMed     Text format     Abstract available


  31. AL-BAHLANI SM, Al-Bulushi KH, Al-Alawi ZM, Al-Abri NY, et al
    Cisplatin Induces Apoptosis Through the Endoplasmic Reticulum-mediated, Calpain 1 Pathway in Triple-negative Breast Cancer Cells.
    Clin Breast Cancer. 2016 Dec 24. pii: S1526-8209(16)30566.
    PubMed     Text format     Abstract available


  32. PEREIRA CB, Leal MF, Abdelhay ES, Demachki S, et al
    MYC Amplification as a Predictive Factor of Complete Pathologic Response to Docetaxel-based Neoadjuvant Chemotherapy for Breast Cancer.
    Clin Breast Cancer. 2016 Dec 24. pii: S1526-8209(16)30570.
    PubMed     Text format     Abstract available


  33. BENEDICT C, Thom B, Teplinsky E, Carleton J, et al
    Family-building After Breast Cancer: Considering the Effect on Adherence to Adjuvant Endocrine Therapy.
    Clin Breast Cancer. 2016 Dec 24. pii: S1526-8209(16)30567.
    PubMed     Text format     Abstract available


    November 2016
  34. XIAO F, Song X, Chen Q, Dai Y, et al
    Effectiveness of Psychological Interventions on Depression in Patients After Breast Cancer Surgery: A Meta-analysis of Randomized Controlled Trials.
    Clin Breast Cancer. 2016 Nov 23. pii: S1526-8209(16)30494.
    PubMed     Text format     Abstract available


  35. GIATROMANOLAKI A, Sivridis E, Kalamida D, Koukourakis MI, et al
    Transcription Factor EB Expression in Early Breast Cancer Relates to Lysosomal/Autophagosomal Markers and Prognosis.
    Clin Breast Cancer. 2016 Nov 23. pii: S1526-8209(16)30497.
    PubMed     Text format     Abstract available


  36. TSENG CH
    Sitagliptin May Reduce Breast Cancer Risk in Women With Type 2 Diabetes.
    Clin Breast Cancer. 2016 Nov 23. pii: S1526-8209(16)30493.
    PubMed     Text format     Abstract available


  37. SATO K, Akimoto K
    Expression Levels of KMT2C and SLC20A1 Identified by Information-theoretical Analysis Are Powerful Prognostic Biomarkers in Estrogen Receptor-positive Breast Cancer.
    Clin Breast Cancer. 2016 Nov 23. pii: S1526-8209(16)30496.
    PubMed     Text format     Abstract available


  38. VILLARREAL-GARZA C, Mohar A, Bargallo-Rocha JE, Lasa-Gonsebatt F, et al
    Molecular Subtypes and Prognosis in Young Mexican Women With Breast Cancer.
    Clin Breast Cancer. 2016 Nov 23. pii: S1526-8209(16)30498.
    PubMed     Text format     Abstract available


  39. MUZAFFAR M, Kachare S, Vohra N
    Impact of Primary Tumor Surgery in Stage IV Male Breast Cancer.
    Clin Breast Cancer. 2016 Nov 22. pii: S1526-8209(16)30492.
    PubMed     Text format     Abstract available


    October 2016
  40. RYU JM, Park S, Paik HJ, Nam SJ, et al
    Oncologic Safety of Immediate Breast Reconstruction in Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy: Short-Term Outcomes of a Matched Case-Control Study.
    Clin Breast Cancer. 2016 Oct 27. pii: S1526-8209(16)30373.
    PubMed     Text format     Abstract available


  41. KIM SH, Shin HJ, Shin KC, Chae EY, et al
    Diagnostic Performance of Fused Diffusion-Weighted Imaging Using T1-Weighted Imaging for Axillary Nodal Staging in Patients With Early Breast Cancer.
    Clin Breast Cancer. 2016 Oct 19. pii: S1526-8209(16)30374.
    PubMed     Text format     Abstract available


  42. OJINNAKA CO, Luo W, Ory MG, McMaughan D, et al
    Disparities in Surgical Treatment of Early-Stage Breast Cancer Among Female Residents of Texas: The Role of Racial Residential Segregation.
    Clin Breast Cancer. 2016 Oct 19. pii: S1526-8209(16)30370.
    PubMed     Text format     Abstract available


  43. LEINERT E, Singer S, Janni W, Harbeck N, et al
    The Impact of Age on Quality of Life in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Comparative Analysis From the Prospective Multicenter Randomized ADEBAR trial.
    Clin Breast Cancer. 2016 Oct 19. pii: S1526-8209(16)30372.
    PubMed     Text format     Abstract available


  44. MARRAZZO A, Damiano G, Taormina P, Buscemi S, et al
    Does Conservative Surgery for Breast Carcinoma Still Require Axillary Lymph Node Evaluation? A Retrospective Analysis of 1156 Consecutive Women With Early Breast Cancer.
    Clin Breast Cancer. 2016 Oct 18. pii: S1526-8209(16)30365.
    PubMed     Text format     Abstract available


    September 2016
  45. DUCHNOWSKA R, Jarzab M, Zebracka-Gala J, Matkowski R, et al
    Brain Metastasis Prediction by Transcriptomic Profiling in Triple-Negative Breast Cancer.
    Clin Breast Cancer. 2016 Sep 8. pii: S1526-8209(16)30238.
    PubMed     Text format     Abstract available


    August 2016
  46. GAO JJ, Tan M, Pohlmann PR, Swain SM, et al
    HALT-D: A Phase II Evaluation of Crofelemer for the Prevention and Prophylaxis of Diarrhea in Patients With Breast Cancer on Pertuzumab-Based Regimens.
    Clin Breast Cancer. 2016 Aug 27. pii: S1526-8209(16)30235.
    PubMed     Text format     Abstract available


  47. GLUCK S
    Consequences of the Convergence of Multiple Alternate Pathways on the Estrogen Receptor in the Treatment of Metastatic Breast Cancer.
    Clin Breast Cancer. 2016 Aug 25. pii: S1526-8209(16)30234.
    PubMed     Text format     Abstract available


  48. PIVO S, Montes J, Schwartz S, Chun J, et al
    Breast Cancer Risk Assessment and Screening in Transgender Patients.
    Clin Breast Cancer. 2016 Aug 25. pii: S1526-8209(16)30233.
    PubMed     Text format    


  49. JASRA S, Opyrchal M, Norton L, Mehta R, et al
    A Rare Case of S310F Somatic ERBB2 Mutation in a HER2-Nonamplified Breast Cancer.
    Clin Breast Cancer. 2016 Aug 18. pii: S1526-8209(16)30211.
    PubMed     Text format    


  50. CADOO KA, Morris PG, Cowell EP, Patil S, et al
    Adjuvant Chemotherapy and Trastuzumab Is Safe and Effective in Older Women With Small, Node-Negative, HER2-Positive Early-Stage Breast Cancer.
    Clin Breast Cancer. 2016 Aug 1. pii: S1526-8209(16)30206.
    PubMed     Text format     Abstract available


    July 2016
  51. YARDLEY DA, Reeves J, Dees EC, Osborne C, et al
    Ramucirumab With Eribulin Versus Eribulin in Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracycline and Taxane Therapy: A Multicenter, Randomized, Phase II Study.
    Clin Breast Cancer. 2016 Jul 29. pii: S1526-8209(16)30198.
    PubMed     Text format     Abstract available


  52. CHOI WJ, Cha JH, Kim HH, Shin HJ, et al
    The Accuracy of Breast MR Imaging for Measuring the Size of a Breast Cancer: Analysis of the Histopathologic Factors.
    Clin Breast Cancer. 2016 Jul 29. pii: S1526-8209(16)30200.
    PubMed     Text format     Abstract available


  53. DUDANI S, Mazzarello S, Hilton J, Hutton B, et al
    Optimal Management of Leptomeningeal Carcinomatosis in Breast Cancer Patients-A Systematic Review.
    Clin Breast Cancer. 2016 Jul 28. pii: S1526-8209(16)30207.
    PubMed     Text format     Abstract available


  54. XUAN Q, Gao K, Song Y, Zhao S, et al
    Adherence to Needed Adjuvant Therapy Could Decrease Recurrence Rates for Rural Patients With Early Breast Cancer.
    Clin Breast Cancer. 2016 Jul 28. pii: S1526-8209(16)30199.
    PubMed     Text format     Abstract available


  55. ZHU W, Harvey S, Macura KJ, Euhus DM, et al
    Invasive Breast Cancer Preferably and Predominantly Occurs at the Interface Between Fibroglandular and Adipose Tissue.
    Clin Breast Cancer. 2016 Jul 28. pii: S1526-8209(16)30202.
    PubMed     Text format     Abstract available


  56. TECALCO-CRUZ AC, Ramirez-Jarquin JO
    Mechanisms that Increase Stability of Estrogen Receptor Alpha in Breast Cancer.
    Clin Breast Cancer. 2016 Jul 28. pii: S1526-8209(16)30208.
    PubMed     Text format     Abstract available


  57. WILKINSON JB, Shah C, Amin M, Nadeau L, et al
    Outcomes According to Breast Cancer Subtype in Patients Treated With Accelerated Partial Breast Irradiation.
    Clin Breast Cancer. 2016 Jul 28. pii: S1526-8209(16)30203.
    PubMed     Text format     Abstract available


  58. SMITH JW 2ND, Buyse ME, Rastogi P, Geyer CE Jr, et al
    Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Tri
    Clin Breast Cancer. 2016 Jul 28. pii: S1526-8209(16)30201.
    PubMed     Text format     Abstract available


  59. MORIKAWA A, Jordan L, Rozner R, Patil S, et al
    Characteristics and Outcomes of Patients With Breast Cancer With Leptomeningeal Metastasis.
    Clin Breast Cancer. 2016 Jul 25. pii: S1526-8209(16)30177.
    PubMed     Text format     Abstract available


  60. EDENFIELD J, Schammel C, Collins J, Schammel D, et al
    Metaplastic Breast Cancer: Molecular Typing and Identification of Potential Targeted Therapies at a Single Institution.
    Clin Breast Cancer. 2016 Jul 25. pii: S1526-8209(16)30197.
    PubMed     Text format     Abstract available


  61. FOGLIETTA J, Inno A, de Iuliis F, Sini V, et al
    Cardiotoxicity of Aromatase Inhibitors in Breast Cancer Patients.
    Clin Breast Cancer. 2016 Jul 25. pii: S1526-8209(16)30196.
    PubMed     Text format     Abstract available


  62. HARRIS SR
    Differentiating the Causes of Spontaneous Rib Fracture After Breast Cancer.
    Clin Breast Cancer. 2016 Jul 15. pii: S1526-8209(16)30176.
    PubMed     Text format     Abstract available


  63. PARK S, Lee JE, Paik HJ, Ryu JM, et al
    Feasibility and Prognostic Effect of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Cytology-Proven, Node-Positive Breast Cancer.
    Clin Breast Cancer. 2016 Jul 9. pii: S1526-8209(16)30175.
    PubMed     Text format     Abstract available


  64. TANAKA K, Tokunaga E, Inoue Y, Yamashita N, et al
    Impact of Expression of Vimentin and Axl in Breast Cancer.
    Clin Breast Cancer. 2016 Jul 5. pii: S1526-8209(16)30170.
    PubMed     Text format     Abstract available


  65. S CHAPMAN J, Roddy E, Panighetti A, Hwang S, et al
    Comparing Coordinated Versus Sequential Salpingo-Oophorectomy for BRCA1 and BRCA2 Mutation Carriers With Breast Cancer.
    Clin Breast Cancer. 2016 Jul 5. pii: S1526-8209(16)30171.
    PubMed     Text format     Abstract available


    June 2016
  66. LEE J, Jung JH, Kim WW, Hwang SO, et al
    Five-Year Oncologic Outcomes of Volume Displacement Procedures After Partial Mastectomy for Breast Cancer.
    Clin Breast Cancer. 2016 Jun 29. pii: S1526-8209(16)30173.
    PubMed     Text format     Abstract available


  67. NAVARRO-RODRIGUEZ E, Diaz-Jimenez N, Ruiz-Rabelo J, Gomez-Luque I, et al
    Factors Associated With Disease Recurrence in Breast Cancer Patients With Negative Sentinel Lymph Node Biopsy.
    Clin Breast Cancer. 2016 Jun 27. pii: S1526-8209(16)30168.
    PubMed     Text format     Abstract available


  68. VARILLA V, Taxel P, Tannenbaum S
    Metastatic Inflammatory Breast Cancer Associated With Multicentric Reticulohistiocytosis Successfully Treated With Zoledronic Acid.
    Clin Breast Cancer. 2016 Jun 25. pii: S1526-8209(16)30166.
    PubMed     Text format    


  69. DE IULIIS F, Salerno G, Corvino R, D'Aniello D, et al
    Anthracycline-Free Neoadjuvant Chemotherapy Ensures Higher Rates of Pathologic Complete Response in Breast Cancer.
    Clin Breast Cancer. 2016 Jun 25. pii: S1526-8209(16)30165.
    PubMed     Text format     Abstract available


  70. ONO M, Tsuda H, Yoshida M, Shimizu C, et al
    Prognostic Significance of Progesterone Receptor Expression in Estrogen-Receptor Positive, HER2-Negative, Node-Negative Invasive Breast Cancer With a Low Ki-67 Labeling Index.
    Clin Breast Cancer. 2016 Jun 25. pii: S1526-8209(16)30167.
    PubMed     Text format     Abstract available


  71. CINIERI S, Chan A, Altundag K, Vandebroek A, et al
    Final Results of the Randomized Phase II NorCap-CA223 Trial Comparing First-Line All-Oral Versus Taxane-Based Chemotherapy for HER2-Negative Metastatic Breast Cancer.
    Clin Breast Cancer. 2016 Jun 25. pii: S1526-8209(16)30169.
    PubMed     Text format     Abstract available


  72. DAUGHERTY EC, Daugherty MR, Bogart JA, Shapiro A, et al
    Adjuvant Radiation Improves Survival in Older Women Following Breast-Conserving Surgery for Estrogen Receptor-Negative Breast Cancer.
    Clin Breast Cancer. 2016 Jun 23. pii: S1526-8209(16)30172.
    PubMed     Text format     Abstract available


  73. RAMAN R, Mott SL, Schroeder MC, Phadke S, et al
    Effect of Body Mass Index- and Actual Weight-Based Neoadjuvant Chemotherapy Doses on Pathologic Complete Response in Operable Breast Cancer.
    Clin Breast Cancer. 2016 Jun 23. pii: S1526-8209(16)30163.
    PubMed     Text format     Abstract available


  74. BUFI E, Belli P, Di Matteo M, Giuliani M, et al
    Hypervascularity Predicts Complete Pathologic Response to Chemotherapy and Late Outcomes in Breast Cancer.
    Clin Breast Cancer. 2016 Jun 23. pii: S1526-8209(16)30162.
    PubMed     Text format     Abstract available


  75. TAKAHASHI H, Kagara N, Tanei T, Naoi Y, et al
    Correlation of Methylated Circulating Tumor DNA With Response to Neoadjuvant Chemotherapy in Breast Cancer Patients.
    Clin Breast Cancer. 2016 Jun 16. pii: S1526-8209(16)30148.
    PubMed     Text format     Abstract available


  76. TZANNINIS IG, Kotteas EA, Ntanasis-Stathopoulos I, Kontogianni P, et al
    Management and Outcomes in Metaplastic Breast Cancer.
    Clin Breast Cancer. 2016 Jun 15. pii: S1526-8209(16)30144.
    PubMed     Text format     Abstract available


  77. GIULIANI M, Patrolecco F, Rella R, Di Giovanni SE, et al
    Can Breast Cancer Biopsy Influence Sentinel Lymph Node Status?
    Clin Breast Cancer. 2016 Jun 14. pii: S1526-8209(16)30147.
    PubMed     Text format     Abstract available


  78. JEHN CF, Hemmati P, Lehenbauer-Dehm S, Kummel S, et al
    Biweekly Pegylated Liposomal Doxorubicin (Caelyx) in Heavily Pretreated Metastatic Breast Cancer: A Phase 2 Study.
    Clin Breast Cancer. 2016 Jun 14. pii: S1526-8209(16)30143.
    PubMed     Text format     Abstract available


  79. ABRAMOVITZ M, Williams C, Loibl S, Leyland-Jones B, et al
    Dual Blockade of HER-2 Provides a Greater Magnitude of Benefit in Patients With Hormone-Negative Versus Hormone-Positive Breast Cancer.
    Clin Breast Cancer. 2016 Jun 14. pii: S1526-8209(16)30146.
    PubMed     Text format     Abstract available


  80. AYTAC HO, Nursal TZ, Colakoglu T, Bolat FA, et al
    Seroma Cytology in Breast Cancer: An Underappreciated Issue.
    Clin Breast Cancer. 2016 Jun 8. pii: S1526-8209(16)30142.
    PubMed     Text format     Abstract available


  81. CEBERIO N, Cuadra M, Mendizabal JL, Gorostiaga J, et al
    Should We Perform the Intraoperative Sentinel Lymph Node Biopsy in Breast Cancer?
    Clin Breast Cancer. 2016 Jun 8. pii: S1526-8209(16)30141.
    PubMed     Text format     Abstract available


  82. TAKEI J, Tsunoda H, Yagata H, Suzuki K, et al
    Sustained Interruption of Anterior Interfaces Between Adipose Tissues and Mammary Glands in Ultrasonography After Complete Pathological Remission After Neoadjuvant Chemotherapy for Primary Breast Cancer.
    Clin Breast Cancer. 2016;16:196-201.
    PubMed     Text format     Abstract available


    May 2016
  83. NEUHAUS V, Abdullayev N, Hellmich M, Kramer S, et al
    Association of Quality and Quantity of Bone Metastases and Computed Tomography Volumetric Bone Mineral Density With Prevalence of Vertebral Fractures in Breast Cancer Patients.
    Clin Breast Cancer. 2016 May 31. pii: S1526-8209(16)30106.
    PubMed     Text format     Abstract available


  84. SHIINO S, Kinoshita T, Yoshida M, Jimbo K, et al
    Prognostic Impact of Discordance in Hormone Receptor Status Between Primary and Recurrent Sites in Patients With Recurrent Breast Cancer.
    Clin Breast Cancer. 2016 May 14. pii: S1526-8209(16)30110.
    PubMed     Text format     Abstract available


  85. AZGHADI S, Daly M, Mayadev J
    Practice Patterns of Radiation Field Design for Sentinel Lymph Node-Positive Early-Stage Breast Cancer.
    Clin Breast Cancer. 2016 May 14. pii: S1526-8209(16)30105.
    PubMed     Text format     Abstract available


  86. NAKAUCHI C, Kagara N, Shimazu K, Shimomura A, et al
    Detection of TP53/PIK3CA Mutations in Cell-Free Plasma DNA From Metastatic Breast Cancer Patients Using Next Generation Sequencing.
    Clin Breast Cancer. 2016 May 14. pii: S1526-8209(16)30100.
    PubMed     Text format     Abstract available


  87. YARDLEY DA, Ward PJ, Daniel BR, Eakle JF, et al
    Panitumumab, Gemcitabine, and Carboplatin as Treatment for Women With Metastatic Triple-Negative Breast Cancer: A Sarah Cannon Research Institute Phase II Trial.
    Clin Breast Cancer. 2016 May 14. pii: S1526-8209(16)30102.
    PubMed     Text format     Abstract available


  88. GANZ PA, Hahn EE, Petersen L, Melisko ME, et al
    Quality of Posttreatment Care Among Breast Cancer Survivors in the University of California Athena Breast Health Network (Athena).
    Clin Breast Cancer. 2016 May 14. pii: S1526-8209(16)30099.
    PubMed     Text format     Abstract available


  89. TANG Y, Wang Y, Kiani MF, Wang B, et al
    Classification, Treatment Strategy, and Associated Drug Resistance in Breast Cancer.
    Clin Breast Cancer. 2016 May 13. pii: S1526-8209(16)30108.
    PubMed     Text format     Abstract available


  90. CHANG JS, Chen J, Weinberg VK, Fowble B, et al
    Evaluation of Heart Dose for Left-Sided Breast Cancer Patients Over an 11-Year Period Spanning the Transition From 2-Dimensional to 3-Dimensional Planning.
    Clin Breast Cancer. 2016 May 13. pii: S1526-8209(16)30109.
    PubMed     Text format     Abstract available


  91. ALGAN O, Zhao YD, Herman T
    Radiotherapy in Patients 70 Years and Older With Triple-Negative Breast Cancer.
    Clin Breast Cancer. 2016 May 13. pii: S1526-8209(16)30107.
    PubMed     Text format     Abstract available


  92. PETRELLI F, Di Cosimo S, Lonati V, Barni S, et al
    Vinorelbine With Capecitabine, an Evergreen Doublet for Advanced Breast Cancer: A Systematic Literature Review and Pooled-Analysis of Phase II-III Studies.
    Clin Breast Cancer. 2016 May 13. pii: S1526-8209(16)30098.
    PubMed     Text format     Abstract available


    April 2016
  93. HAMELINCK VC, Bastiaannet E, Pieterse AH, de Glas NA, et al
    A Prospective Comparison of Younger and Older Patients' Preferences for Adjuvant Chemotherapy and Hormonal Therapy in Early Breast Cancer.
    Clin Breast Cancer. 2016 Apr 21. pii: S1526-8209(16)30083.
    PubMed     Text format     Abstract available


    March 2016
  94. LOVE RR
    Adjuvant Surgical Oophorectomy Plus Tamoxifen in Premenopausal Women With Operable Hormone Receptor-Positive Breast Cancer: A Global Treatment Option.
    Clin Breast Cancer. 2016 Mar 31. pii: S1526-8209(16)30078.
    PubMed     Text format     Abstract available


  95. TRUIN W, Roumen RM, Siesling S, van der Heiden-van der Loo M, et al
    Sentinel Lymph Node Biopsy and Isolated Tumor Cells in Invasive Lobular Versus Ductal Breast Cancer.
    Clin Breast Cancer. 2016 Mar 31. pii: S1526-8209(16)30082.
    PubMed     Text format     Abstract available


  96. HURTADO-DE-MENDOZA A, Cabling ML, Lobo T, Dash C, et al
    Behavioral Interventions to Enhance Adherence to Hormone Therapy in Breast Cancer Survivors: A Systematic Literature Review.
    Clin Breast Cancer. 2016 Mar 31. pii: S1526-8209(16)30081.
    PubMed     Text format     Abstract available


  97. WISINSKI KB, Xu W, Tevaarwerk AJ, Saha S, et al
    Targeting Estrogen Receptor Beta in a Phase 2 Study of High-Dose Estradiol in Metastatic Triple-Negative Breast Cancer: A Wisconsin Oncology Network Study.
    Clin Breast Cancer. 2016 Mar 31. pii: S1526-8209(16)30080.
    PubMed     Text format     Abstract available


  98. LEUNG RC, Yau TC, Chan MC, Chan SW, et al
    The Impact of the Oncotype DX Breast Cancer Assay on Treatment Decisions for Women With Estrogen Receptor-Positive, Node-Negative Breast Carcinoma in Hong Kong.
    Clin Breast Cancer. 2016 Mar 17. pii: S1526-8209(16)30077.
    PubMed     Text format     Abstract available


  99. OHNO S
    Tolerability of Therapies Recommended for the Treatment of Hormone Receptor-Positive Locally Advanced or Metastatic Breast Cancer.
    Clin Breast Cancer. 2016 Mar 12. pii: S1526-8209(16)30049.
    PubMed     Text format     Abstract available


  100. ERBES T, Stickeler E, Rucker G, Buroh S, et al
    BMI and Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer: A Study and Meta-Analysis.
    Clin Breast Cancer. 2016 Mar 9. pii: S1526-8209(16)30048.
    PubMed     Text format     Abstract available


  101. ROUE T, Labbe S, Belliardo S, Plenet J, et al
    Predictive Factors of the Survival of Women With Invasive Breast Cancer in French Guiana: The Burden of Health Inequalities.
    Clin Breast Cancer. 2016 Mar 8. pii: S1526-8209(16)30047.
    PubMed     Text format     Abstract available


    February 2016
  102. BISWAS T, Efird JT, Prasad S, James SE, et al
    Inflammatory TNBC Breast Cancer: Demography and Clinical Outcome in a Large Cohort of Patients With TNBC.
    Clin Breast Cancer. 2016 Feb 13. pii: S1526-8209(16)30024.
    PubMed     Text format     Abstract available


  103. YARDLEY DA, Dickson N, Drosick D, Earwood C, et al
    Sorafenib Plus Ixabepilone as First-Line Treatment of Metastatic HER2-Negative Breast Cancer: A Sarah Cannon Research Institute Phase I/II Trial.
    Clin Breast Cancer. 2016 Feb 12. pii: S1526-8209(16)30023.
    PubMed     Text format     Abstract available


  104. SAHA P, Amico AL, Olopade OI
    Long-Term Disease-Free Survival in a Young Patient With Hormone Receptor-Positive Breast Cancer and Oligometastatic Disease in the Brain.
    Clin Breast Cancer. 2016 Feb 12. pii: S1526-8209(16)30033.
    PubMed     Text format    


  105. VERMA V, Shah C, Mehta MP
    Clinical Outcomes and Toxicity of Proton Radiotherapy for Breast Cancer.
    Clin Breast Cancer. 2016 Feb 12. pii: S1526-8209(16)30026.
    PubMed     Text format     Abstract available


  106. HAN HS, Magliocco AM
    Molecular Testing and the Pathologist's Role in Clinical Trials of Breast Cancer.
    Clin Breast Cancer. 2016 Feb 12. pii: S1526-8209(16)30036.
    PubMed     Text format     Abstract available


  107. GALLICCHIO L, Calhoun C, Helzlsouer K
    Effect of Aromatase Inhibitor Therapy on the Cardiovascular Health of Black and White Breast Cancer Patients.
    Clin Breast Cancer. 2016 Feb 11. pii: S1526-8209(16)30031.
    PubMed     Text format     Abstract available


  108. TELFORD C, Jones N, Livings C, Batson S, et al
    Network Meta-Analysis Comparing Overall Survival for Fulvestrant 500 mg Versus Alternative Therapies for Treatment of Postmenopausal, Estrogen Receptor-Positive Advanced Breast Cancer Following Failure on Prior Endocrine Therapy.
    Clin Breast Cancer. 2016 Feb 11. pii: S1526-8209(16)30027.
    PubMed     Text format     Abstract available


  109. ENOKIDO K, Watanabe C, Nakamura S, Ogiya A, et al
    Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients With an Initial Diagnosis of Cytology-Proven Lymph Node-Positive Breast Cancer.
    Clin Breast Cancer. 2016 Feb 11. pii: S1526-8209(16)30029.
    PubMed     Text format     Abstract available


  110. KIM HR, Jung HK, Ko KH, Kim SJ, et al
    Mammography, US, and MRI for Preoperative Prediction of Extensive Intraductal Component of Invasive Breast Cancer: Interobserver Variability and Performances.
    Clin Breast Cancer. 2016 Feb 11. pii: S1526-8209(16)30025.
    PubMed     Text format     Abstract available


    December 2015
  111. KARAVASILIS V, Papadimitriou C, Gogas H, Kouvatseas G, et al
    Safety and Tolerability of Anthracycline-Containing Adjuvant Chemotherapy in Elderly High-Risk Breast Cancer Patients.
    Clin Breast Cancer. 2015 Dec 17. pii: S1526-8209(15)00296.
    PubMed     Text format     Abstract available


  112. YU JI, Park W, Choi DH, Huh SJ, et al
    Limited Supraclavicular Radiation Field in Breast Cancer With >/= 10 Positive Axillary Lymph Nodes.
    Clin Breast Cancer. 2015 Dec 11. pii: S1526-8209(15)00281.
    PubMed     Text format     Abstract available


    November 2015
  113. ZAENGER D, Rabatic BM, Dasher B, Mourad WF, et al
    Is Breast Conserving Therapy a Safe Modality for Early-Stage Male Breast Cancer?
    Clin Breast Cancer. 2015 Nov 17. pii: S1526-8209(15)00278.
    PubMed     Text format     Abstract available


  114. FRIEDMAN MD, Lacouture M, Dang C
    Dermatologic Adverse Events Associated With Use of Adjuvant Lapatinib in Combination With Paclitaxel and Trastuzumab for HER2-Positive Breast Cancer: A Case Series Analysis.
    Clin Breast Cancer. 2015 Nov 17. pii: S1526-8209(15)00274.
    PubMed     Text format    


  115. WILSON S, Speers C, Tyldesley S, Chia S, et al
    Risk of Recurrence or Contralateral Breast Cancer More than 5 Years After Diagnosis of Hormone Receptor-Positive Early-Stage Breast Cancer.
    Clin Breast Cancer. 2015 Nov 17. pii: S1526-8209(15)00275.
    PubMed     Text format     Abstract available


  116. TAN WW, Allred JB, Moreno-Aspitia A, Northfelt DW, et al
    Phase I Study of Panobinostat (LBH589) and Letrozole in Postmenopausal Metastatic Breast Cancer Patients.
    Clin Breast Cancer. 2015 Nov 17. pii: S1526-8209(15)00276.
    PubMed     Text format     Abstract available


  117. IWAMOTO T, Kelly C, Mizoo T, Nogami T, et al
    Relative Prognostic and Predictive Value of Gene Signature and Histologic Grade in Estrogen Receptor-Positive, HER2-Negative Breast Cancer.
    Clin Breast Cancer. 2015 Nov 10. pii: S1526-8209(15)00242.
    PubMed     Text format     Abstract available


  118. SHACHAR SS, Fried G, Drumea K, Shafran N, et al
    Physicians' Considerations for Repeat Biopsy in Patients With Recurrent Metastatic Breast Cancer.
    Clin Breast Cancer. 2015 Nov 10. pii: S1526-8209(15)00244.
    PubMed     Text format     Abstract available


  119. GOMEZ HL, Neciosup S, Tosello C, Mano M, et al
    A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study).
    Clin Breast Cancer. 2015 Nov 10. pii: S1526-8209(15)00243.
    PubMed     Text format     Abstract available


  120. EL SHAROUNI MA, Postma EL, Menezes GL, van den Bosch MA, et al
    High Prevalence of MRI-Detected Contralateral and Ipsilateral Malignant Findings in Patients With Invasive Ductolobular Breast Cancer: Impact on Surgical Management.
    Clin Breast Cancer. 2015 Nov 10. pii: S1526-8209(15)00240.
    PubMed     Text format     Abstract available


    September 2015
  121. SACHDEV JC, Jahanzeb M
    Use of Cytotoxic Chemotherapy in Metastatic Breast Cancer: Putting Taxanes in Perspective.
    Clin Breast Cancer. 2015 Sep 25. pii: S1526-8209(15)00218.
    PubMed     Text format     Abstract available


  122. VAN DEN HOVEN I, van Klaveren D, Voogd AC, Vergouwe Y, et al
    A Dutch Prediction Tool to Assess the Risk of Additional Axillary Non-Sentinel Lymph Node Involvement in Sentinel Node-Positive Breast Cancer Patients.
    Clin Breast Cancer. 2015 Sep 21. pii: S1526-8209(15)00214.
    PubMed     Text format     Abstract available


    July 2015
  123. CHILDERS WK, Hollenbeak CS, Cheriyath P
    beta-Blockers Reduce Breast Cancer Recurrence and Breast Cancer Death: A Meta-Analysis.
    Clin Breast Cancer. 2015 Jul 10. pii: S1526-8209(15)00147.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: